Mesoblast Limited (ASX:MSB)
Australia · Delayed Price · Currency is AUD 2.460
+0.050 (2.07%)
Aug 28, 2026, 4:10 PM AEST
Mesoblast Income Statement
Financials in millions USD. Fiscal year is July - June.
Millions USD. Fiscal year is Jul - Jun.
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
| 120.25 | 17.2 | 5.9 | 7.5 | 10.21 | |
Revenue Growth | 599.21% | 191.39% | -21.32% | -26.54% | 37.35% |
Cost of Revenue | 24.03 | 17.62 | 2.95 | 52.82 | 63.57 |
Gross Profit | 96.22 | -0.42 | 2.95 | -45.32 | -53.36 |
Selling, General & Admin | 57.35 | 39.31 | 24.98 | 27.48 | 27.21 |
Research & Development | 90.15 | 22.32 | 36.77 | - | - |
Other Operating Expenses | -0.02 | 0.4 | -0.73 | -3.51 | 0 |
Operating Expenses | 147.47 | 62.02 | 61.01 | 23.97 | 27.21 |
Operating Income | -51.25 | -62.44 | -58.06 | -69.29 | -80.57 |
Interest Expense | -19.87 | -21.75 | -20.66 | -19.44 | -16.91 |
Interest & Investment Income | 3.91 | 3.55 | 0.36 | 0.83 | 0 |
Currency Exchange Gain (Loss) | 1.07 | -0.11 | 1.18 | -0.16 | -0.54 |
Other Non Operating Income (Expenses) | -3.11 | -6.18 | -1.57 | -2.88 | 5.51 |
EBT Excluding Unusual Items | -69.25 | -86.93 | -78.76 | -90.95 | -92.5 |
Asset Writedown | -0.09 | - | -0.09 | 0.08 | - |
Other Unusual Items | 12.45 | -14.89 | -9.31 | 8.77 | 0.91 |
Pretax Income | -56.89 | -101.81 | -88.15 | -82.1 | -91.59 |
Income Tax Expense | 0.61 | 0.33 | -0.19 | -0.21 | -0.24 |
Net Income | -57.5 | -102.14 | -87.96 | -81.89 | -91.35 |
Net Income to Common | -57.5 | -102.14 | -87.96 | -81.89 | -91.35 |
Net Income Growth | - | - | - | - | - |
Shares Outstanding (Basic) | 1,295 | 1,208 | 987 | 778 | 683 |
Shares Outstanding (Diluted) | 1,295 | 1,208 | 987 | 778 | 683 |
Shares Change | 7.21% | 22.41% | 26.87% | 13.89% | 12.86% |
EPS (Basic) | -0.04 | -0.08 | -0.09 | -0.11 | -0.13 |
EPS (Diluted) | -0.04 | -0.08 | -0.09 | -0.11 | -0.13 |
EPS Growth | - | - | - | - | - |
Additional Metrics
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Free Cash Flow | -44.66 | -50.63 | -48.73 | -63.53 | -65.94 |
Free Cash Flow Per Share | -0.03 | -0.04 | -0.05 | -0.08 | -0.10 |
Gross Margin | 80.02% | -2.44% | 50.02% | - | - |
Operating Margin | -42.62% | -363.08% | -983.77% | -923.73% | -789.09% |
Profit Margin | -47.82% | -593.92% | -1490.27% | -1091.71% | -894.59% |
Free Cash Flow Margin | -37.14% | -294.42% | -825.63% | -846.99% | -645.76% |
EBITDA | -45.01 | -58.18 | -56.17 | -66.84 | -77.91 |
EBITDA Margin | -37.43% | - | - | - | - |
D&A For EBITDA | 6.25 | 4.26 | 1.9 | 2.45 | 2.66 |
EBIT | -51.25 | -62.44 | -58.06 | -69.29 | -80.57 |
EBIT Margin | -42.62% | - | - | - | - |
Revenue as Reported | 120.25 | 17.2 | 5.9 | 7.5 | - |